APO Research
Talk to an analyst

APO RESEARCH · REPORT

Abortion Medication

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Abortion Medication Market Analysis and Forecast 2026-2032

23 December 2025192 pages

Choose your research edition.

Industry ResearchAbortion Medication Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Abortion Medication Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Abortion Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Abortion Medication Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Abortion Medication Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Abortion Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Abortion Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Abortion Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Abortion Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Abortion Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Abortion Medication include Cadila, Cipla, Exelgyn Laboratories, GenBioPro, Zizhu-pharm, Shanghai Xinhualian Pharmaceutical Co., Ltd and Sun Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Abortion Medication, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Abortion Medication, also provides the sales of main regions and countries. Of the upcoming market potential for Abortion Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Abortion Medication sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Abortion Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Abortion Medication sales, projected growth trends, production technology, application and end-user industry.

Abortion Medication Segment by Company

Cadila

Cipla

Exelgyn Laboratories

GenBioPro

Zizhu-pharm

Shanghai Xinhualian Pharmaceutical Co., Ltd

Sun Pharma

Abortion Medication Segment by Type

Mifepristone

Misoprostol

Abortion Medication Segment by Application

Clinic

Hospital

Others

Abortion Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Abortion Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Abortion Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Abortion Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Abortion Medication in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Abortion Medication manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Abortion Medication sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Abortion Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Mifepristone Major Manufacturers Table 3. Misoprostol Major Manufacturers Table 4. Global Abortion Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Others Major Manufacturers Table 8. Abortion Medication Industry Trends Table 9. Abortion Medication Industry Drivers Table 10. Abortion Medication Industry Opportunities and Challenges Table 11. Abortion Medication Industry Restraints Table 12. Global Abortion Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Abortion Medication Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Abortion Medication Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Abortion Medication Revenue Market Share by Region (2021-2026) Table 16. Global Abortion Medication Revenue Market Share by Region (2027-2032) Table 17. Global Abortion Medication Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Abortion Medication Sales by Region (2021-2026) & (k units) Table 19. Global Abortion Medication Sales by Region (2027-2032) & (k units) Table 20. Global Abortion Medication Sales Market Share by Region (2021-2026) Table 21. Global Abortion Medication Sales Market Share by Region (2027-2032) Table 22. Global Abortion Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Abortion Medication Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Abortion Medication Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Abortion Medication Sales Market Share by Manufacturers (2021-2026) Table 26. Global Abortion Medication Sales Price (USD/unit) of Manufacturers (2021-2026) Table 27. Global Abortion Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Abortion Medication Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Abortion Medication Manufacturers, Product Type & Application Table 30. Global Abortion Medication Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Abortion Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Abortion Medication Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Abortion Medication Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Abortion Medication Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Abortion Medication Revenue Market Share by Type (2021-2026) Table 37. Global Abortion Medication Revenue Market Share by Type (2027-2032) Table 38. Global Abortion Medication Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Abortion Medication Sales by Type (2021-2026) & (k units) Table 40. Global Abortion Medication Sales by Type (2027-2032) & (k units) Table 41. Global Abortion Medication Sales Market Share by Type (2021-2026) Table 42. Global Abortion Medication Sales Market Share by Type (2027-2032) Table 43. Global Abortion Medication Price by Type (2021-2026) & (USD/unit) Table 44. Global Abortion Medication Price by Type (2027-2032) & (USD/unit) Table 45. Global Abortion Medication Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Abortion Medication Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Abortion Medication Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Abortion Medication Revenue Market Share by Application (2021-2026) Table 49. Global Abortion Medication Revenue Market Share by Application (2027-2032) Table 50. Global Abortion Medication Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Abortion Medication Sales by Application (2021-2026) & (k units) Table 52. Global Abortion Medication Sales by Application (2027-2032) & (k units) Table 53. Global Abortion Medication Sales Market Share by Application (2021-2026) Table 54. Global Abortion Medication Sales Market Share by Application (2027-2032) Table 55. Global Abortion Medication Price by Application (2021-2026) & (USD/unit) Table 56. Global Abortion Medication Price by Application (2027-2032) & (USD/unit) Table 57. Cadila Company Information Table 58. Cadila Business Overview Table 59. Cadila Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 60. Cadila Abortion Medication Product Portfolio Table 61. Cadila Recent Development Table 62. Cipla Company Information Table 63. Cipla Business Overview Table 64. Cipla Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 65. Cipla Abortion Medication Product Portfolio Table 66. Cipla Recent Development Table 67. Exelgyn Laboratories Company Information Table 68. Exelgyn Laboratories Business Overview Table 69. Exelgyn Laboratories Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Exelgyn Laboratories Abortion Medication Product Portfolio Table 71. Exelgyn Laboratories Recent Development Table 72. GenBioPro Company Information Table 73. GenBioPro Business Overview Table 74. GenBioPro Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. GenBioPro Abortion Medication Product Portfolio Table 76. GenBioPro Recent Development Table 77. Zizhu-pharm Company Information Table 78. Zizhu-pharm Business Overview Table 79. Zizhu-pharm Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Zizhu-pharm Abortion Medication Product Portfolio Table 81. Zizhu-pharm Recent Development Table 82. Shanghai Xinhualian Pharmaceutical Co., Ltd Company Information Table 83. Shanghai Xinhualian Pharmaceutical Co., Ltd Business Overview Table 84. Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Product Portfolio Table 86. Shanghai Xinhualian Pharmaceutical Co., Ltd Recent Development Table 87. Sun Pharma Company Information Table 88. Sun Pharma Business Overview Table 89. Sun Pharma Abortion Medication Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Sun Pharma Abortion Medication Product Portfolio Table 91. Sun Pharma Recent Development Table 92. North America Abortion Medication Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Abortion Medication Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Abortion Medication Sales by Type (2021-2026) & (k units) Table 95. North America Abortion Medication Sales by Type (2027-2032) & (k units) Table 96. North America Abortion Medication Sales Price by Type (2021-2026) & (USD/unit) Table 97. North America Abortion Medication Sales Price by Type (2027-2032) & (USD/unit) Table 98. North America Abortion Medication Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Abortion Medication Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Abortion Medication Sales by Application (2021-2026) & (k units) Table 101. North America Abortion Medication Sales by Application (2027-2032) & (k units) Table 102. North America Abortion Medication Sales Price by Application (2021-2026) & (USD/unit) Table 103. North America Abortion Medication Sales Price by Application (2027-2032) & (USD/unit) Table 104. North America Abortion Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Abortion Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Abortion Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Abortion Medication Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 108. North America Abortion Medication Sales by Country (2021-2026) & (k units) Table 109. North America Abortion Medication Sales by Country (2027-2032) & (k units) Table 110. North America Abortion Medication Sales Price by Country (2021-2026) & (USD/unit) Table 111. North America Abortion Medication Sales Price by Country (2027-2032) & (USD/unit) Table 112. United States Abortion Medication Revenue (2021-2032) & (US$ Million) Table 113. Canada Abortion Medication Revenue (2021-2032) & (US$ Million) Table 114. Mexico Abortion Medication Revenue (2021-2032) & (US$ Million) Table 115. Europe Abortion Medication Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Abortion Medication Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Abortion Medication Sales by Type (2021-2026) & (k units) Table 118. Europe Abortion Medication Sales by Type (2027-2032) & (k units) Table 119. Europe Abortion Medication Sales Price by Type (2021-2026) & (USD/unit) Table 120. Europe Abortion Medication Sales Price by Type (2027-2032) & (USD/unit) Table 121. Europe Abortion Medication Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Abortion Medication Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Abortion Medication Sales by Application (2021-2026) & (k units) Table 124. Europe Abortion Medication Sales by Application (2027-2032) & (k units) Table 125. Europe Abortion Medication Sales Price by Application (2021-2026) & (USD/unit) Table 126. Europe Abortion Medication Sales Price by Application (2027-2032) & (USD/unit) Table 127. Europe Abortion Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Abortion Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Abortion Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Abortion Medication Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 131. Europe Abortion Medication Sales by Country (2021-2026) & (k units) Table 132. Europe Abortion Medication Sales by Country (2027-2032) & (k units) Table 133. Europe Abortion Medication Sales Price by Country (2021-2026) & (USD/unit) Table 134. Europe Abortion Medication Sales Price by Country (2027-2032) & (USD/unit) Table 135. Germany Abortion Medication Revenue (2021-2032) & (US$ Million) Table 136. France Abortion Medication Revenue (2021-2032) & (US$ Million) Table 137. U.K. Abortion Medication Revenue (2021-2032) & (US$ Million) Table 138. Italy Abortion Medication Revenue (2021-2032) & (US$ Million) Table 139. Russia Abortion Medication Revenue (2021-2032) & (US$ Million) Table 140. Spain Abortion Medication Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Abortion Medication Revenue (2021-2032) & (US$ Million) Table 142. Switzerland Abortion Medication Revenue (2021-2032) & (US$ Million) Table 143. Sweden Abortion Medication Revenue (2021-2032) & (US$ Million) Table 144. Poland Abortion Medication Revenue (2021-2032) & (US$ Million) Table 145. China Abortion Medication Revenue by Type (2021-2026) & (US$ Million) Table 146. China Abortion Medication Revenue by Type (2027-2032) & (US$ Million) Table 147. China Abortion Medication Sales by Type (2021-2026) & (k units) Table 148. China Abortion Medication Sales by Type (2027-2032) & (k units) Table 149. China Abortion Medication Sales Price by Type (2021-2026) & (USD/unit) Table 150. China Abortion Medication Sales Price by Type (2027-2032) & (USD/unit) Table 151. China Abortion Medication Revenue by Application (2021-2026) & (US$ Million) Table 152. China Abortion Medication Revenue by Application (2027-2032) & (US$ Million) Table 153. China Abortion Medication Sales by Application (2021-2026) & (k units) Table 154. China Abortion Medication Sales by Application (2027-2032) & (k units) Table 155. China Abortion Medication Sales Price by Application (2021-2026) & (USD/unit) Table 156. China Abortion Medication Sales Price by Application (2027-2032) & (USD/unit) Table 157. Asia Abortion Medication Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Abortion Medication Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Abortion Medication Sales by Type (2021-2026) & (k units) Table 160. Asia Abortion Medication Sales by Type (2027-2032) & (k units) Table 161. Asia Abortion Medication Sales Price by Type (2021-2026) & (USD/unit) Table 162. Asia Abortion Medication Sales Price by Type (2027-2032) & (USD/unit) Table 163. Asia Abortion Medication Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Abortion Medication Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Abortion Medication Sales by Application (2021-2026) & (k units) Table 166. Asia Abortion Medication Sales by Application (2027-2032) & (k units) Table 167. Asia Abortion Medication Sales Price by Application (2021-2026) & (USD/unit) Table 168. Asia Abortion Medication Sales Price by Application (2027-2032) & (USD/unit) Table 169. Asia Abortion Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Abortion Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Abortion Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Abortion Medication Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 173. Asia Abortion Medication Sales by Country (2021-2026) & (k units) Table 174. Asia Abortion Medication Sales by Country (2027-2032) & (k units) Table 175. Asia Abortion Medication Sales Price by Country (2021-2026) & (USD/unit) Table 176. Asia Abortion Medication Sales Price by Country (2027-2032) & (USD/unit) Table 177. Japan Abortion Medication Revenue (2021-2032) & (US$ Million) Table 178. South Korea Abortion Medication Revenue (2021-2032) & (US$ Million) Table 179. India Abortion Medication Revenue (2021-2032) & (US$ Million) Table 180. Australia Abortion Medication Revenue (2021-2032) & (US$ Million) Table 181. Taiwan Abortion Medication Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Abortion Medication Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Abortion Medication Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Abortion Medication Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Abortion Medication Sales by Type (2021-2026) & (k units) Table 186. SAMEA Abortion Medication Sales by Type (2027-2032) & (k units) Table 187. SAMEA Abortion Medication Sales Price by Type (2021-2026) & (USD/unit) Table 188. SAMEA Abortion Medication Sales Price by Type (2027-2032) & (USD/unit) Table 189. SAMEA Abortion Medication Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Abortion Medication Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Abortion Medication Sales by Application (2021-2026) & (k units) Table 192. SAMEA Abortion Medication Sales by Application (2027-2032) & (k units) Table 193. SAMEA Abortion Medication Sales Price by Application (2021-2026) & (USD/unit) Table 194. SAMEA Abortion Medication Sales Price by Application (2027-2032) & (USD/unit) Table 195. SAMEA Abortion Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Abortion Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Abortion Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Abortion Medication Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 199. SAMEA Abortion Medication Sales by Country (2021-2026) & (k units) Table 200. SAMEA Abortion Medication Sales by Country (2027-2032) & (k units) Table 201. SAMEA Abortion Medication Sales Price by Country (2021-2026) & (USD/unit) Table 202. SAMEA Abortion Medication Sales Price by Country (2027-2032) & (USD/unit) Table 203. Brazil Abortion Medication Revenue (2021-2032) & (US$ Million) Table 204. Argentina Abortion Medication Revenue (2021-2032) & (US$ Million) Table 205. Chile Abortion Medication Revenue (2021-2032) & (US$ Million) Table 206. Colombia Abortion Medication Revenue (2021-2032) & (US$ Million) Table 207. Peru Abortion Medication Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Abortion Medication Revenue (2021-2032) & (US$ Million) Table 209. Israel Abortion Medication Revenue (2021-2032) & (US$ Million) Table 210. UAE Abortion Medication Revenue (2021-2032) & (US$ Million) Table 211. Turkey Abortion Medication Revenue (2021-2032) & (US$ Million) Table 212. Iran Abortion Medication Revenue (2021-2032) & (US$ Million) Table 213. Egypt Abortion Medication Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Abortion Medication Distributors List Table 217. Abortion Medication Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Abortion Medication Image Figure 2. Global Abortion Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Abortion Medication Market Size Share 2021 VS 2025 VS 2032 Figure 4. Mifepristone Image Figure 5. Misoprostol Image Figure 6. Global Abortion Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Abortion Medication Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Others Image Figure 11. Global Abortion Medication Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Abortion Medication Revenue (2021-2032) & (US$ Million) Figure 13. Global Abortion Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Abortion Medication Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Abortion Medication Revenue Market Share by Region (2021-2032) Figure 16. Global Abortion Medication Sales (2021-2032) & (k units) Figure 17. Global Abortion Medication Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Abortion Medication Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Abortion Medication Sales YoY (2021-2032) & (k units) Figure 20. Europe Abortion Medication Sales YoY (2021-2032) & (k units) Figure 21. China Abortion Medication Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Abortion Medication Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Abortion Medication Sales YoY (2021-2032) & (k units) Figure 24. Global Abortion Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Abortion Medication Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Abortion Medication Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Abortion Medication Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Abortion Medication Revenue Market Share by Type (2021-2032) Figure 30. Global Abortion Medication Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Abortion Medication Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Abortion Medication Sales Market Share by Type (2021-2032) Figure 33. Global Abortion Medication Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Abortion Medication Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Abortion Medication Revenue Market Share by Application (2021-2032) Figure 36. Global Abortion Medication Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Abortion Medication Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Abortion Medication Sales Market Share by Application (2021-2032) Figure 39. North America Abortion Medication Revenue Share by Type (2021-2032) Figure 40. North America Abortion Medication Sales Share by Type (2021-2032) Figure 41. North America Abortion Medication Revenue Share by Application (2021-2032) Figure 42. North America Abortion Medication Sales Share by Application (2021-2032) Figure 43. North America Abortion Medication Revenue Share by Country (2021-2032) Figure 44. North America Abortion Medication Sales Share by Country (2021-2032) Figure 45. Europe Abortion Medication Revenue Share by Type (2021-2032) Figure 46. Europe Abortion Medication Sales Share by Type (2021-2032) Figure 47. Europe Abortion Medication Revenue Share by Application (2021-2032) Figure 48. Europe Abortion Medication Sales Share by Application (2021-2032) Figure 49. Europe Abortion Medication Revenue Share by Country (2021-2032) Figure 50. Europe Abortion Medication Sales Share by Country (2021-2032) Figure 51. China Abortion Medication Revenue Share by Type (2021-2032) Figure 52. China Abortion Medication Sales Share by Type (2021-2032) Figure 53. China Abortion Medication Revenue Share by Application (2021-2032) Figure 54. China Abortion Medication Sales Share by Application (2021-2032) Figure 55. Asia Abortion Medication Revenue Share by Type (2021-2032) Figure 56. Asia Abortion Medication Sales Share by Type (2021-2032) Figure 57. Asia Abortion Medication Revenue Share by Application (2021-2032) Figure 58. Asia Abortion Medication Sales Share by Application (2021-2032) Figure 59. Asia Abortion Medication Revenue Share by Country (2021-2032) Figure 60. Asia Abortion Medication Sales Share by Country (2021-2032) Figure 61. SAMEA Abortion Medication Revenue Share by Type (2021-2032) Figure 62. SAMEA Abortion Medication Sales Share by Type (2021-2032) Figure 63. SAMEA Abortion Medication Revenue Share by Application (2021-2032) Figure 64. SAMEA Abortion Medication Sales Share by Application (2021-2032) Figure 65. SAMEA Abortion Medication Revenue Share by Country (2021-2032) Figure 66. SAMEA Abortion Medication Sales Share by Country (2021-2032) Figure 67. Abortion Medication Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Abortion Medication Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Mifepristone
  • Misoprostol
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Cadila
  • Cipla
  • Exelgyn Laboratories
  • GenBioPro
  • Zizhu-pharm
  • Shanghai Xinhualian Pharmaceutical Co., Ltd
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Abortion Medication Market by Type
  3. 1.2.1 Global Abortion Medication Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Mifepristone
  5. 1.2.3 Misoprostol
  6. 1.3 Abortion Medication Market by Application
  7. 1.3.1 Global Abortion Medication Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Abortion Medication Market Dynamics
  1. 2.1 Abortion Medication Industry Trends
  2. 2.2 Abortion Medication Industry Drivers
  3. 2.3 Abortion Medication Industry Opportunities and Challenges
  4. 2.4 Abortion Medication Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Abortion Medication Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Abortion Medication Revenue by Region
  3. 3.2.1 Global Abortion Medication Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Abortion Medication Revenue by Region (2021-2026)
  5. 3.2.3 Global Abortion Medication Revenue by Region (2027-2032)
  6. 3.2.4 Global Abortion Medication Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Abortion Medication Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Abortion Medication Sales by Region
  9. 3.4.1 Global Abortion Medication Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Abortion Medication Sales by Region (2021-2026)
  11. 3.4.3 Global Abortion Medication Sales by Region (2027-2032)
  12. 3.4.4 Global Abortion Medication Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Abortion Medication Revenue by Manufacturers
  2. 4.1.1 Global Abortion Medication Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Abortion Medication Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Abortion Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Abortion Medication Sales by Manufacturers
  6. 4.2.1 Global Abortion Medication Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Abortion Medication Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Abortion Medication Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Abortion Medication Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Abortion Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Abortion Medication Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Abortion Medication Manufacturers, Product Type & Application
  13. 4.7 Global Abortion Medication Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Abortion Medication Market CR5 and HHI
  16. 4.8.2 2025 Abortion Medication Tier 1, Tier 2, and Tier 3
5 Abortion Medication Market by Type
  1. 5.1 Global Abortion Medication Revenue by Type
  2. 5.1.1 Global Abortion Medication Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Abortion Medication Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Abortion Medication Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Abortion Medication Sales by Type
  6. 5.2.1 Global Abortion Medication Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Abortion Medication Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Abortion Medication Sales Market Share by Type (2021-2032)
  9. 5.3 Global Abortion Medication Price by Type
6 Abortion Medication Market by Application
  1. 6.1 Global Abortion Medication Revenue by Application
  2. 6.1.1 Global Abortion Medication Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Abortion Medication Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Abortion Medication Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Abortion Medication Sales by Application
  6. 6.2.1 Global Abortion Medication Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Abortion Medication Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Abortion Medication Sales Market Share by Application (2021-2032)
  9. 6.3 Global Abortion Medication Price by Application
7 Company Profiles
  1. 7.1 Cadila
  2. 7.1.1 Cadila Company Information
  3. 7.1.2 Cadila Business Overview
  4. 7.1.3 Cadila Abortion Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Cadila Abortion Medication Product Portfolio
  6. 7.1.5 Cadila Recent Developments
  7. 7.2 Cipla
  8. 7.2.1 Cipla Company Information
  9. 7.2.2 Cipla Business Overview
  10. 7.2.3 Cipla Abortion Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Cipla Abortion Medication Product Portfolio
  12. 7.2.5 Cipla Recent Developments
  13. 7.3 Exelgyn Laboratories
  14. 7.3.1 Exelgyn Laboratories Company Information
  15. 7.3.2 Exelgyn Laboratories Business Overview
  16. 7.3.3 Exelgyn Laboratories Abortion Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Exelgyn Laboratories Abortion Medication Product Portfolio
  18. 7.3.5 Exelgyn Laboratories Recent Developments
  19. 7.4 GenBioPro
  20. 7.4.1 GenBioPro Company Information
  21. 7.4.2 GenBioPro Business Overview
  22. 7.4.3 GenBioPro Abortion Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GenBioPro Abortion Medication Product Portfolio
  24. 7.4.5 GenBioPro Recent Developments
  25. 7.5 Zizhu-pharm
  26. 7.5.1 Zizhu-pharm Company Information
  27. 7.5.2 Zizhu-pharm Business Overview
  28. 7.5.3 Zizhu-pharm Abortion Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Zizhu-pharm Abortion Medication Product Portfolio
  30. 7.5.5 Zizhu-pharm Recent Developments
  31. 7.6 Shanghai Xinhualian Pharmaceutical Co., Ltd
  32. 7.6.1 Shanghai Xinhualian Pharmaceutical Co., Ltd Company Information
  33. 7.6.2 Shanghai Xinhualian Pharmaceutical Co., Ltd Business Overview
  34. 7.6.3 Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Xinhualian Pharmaceutical Co., Ltd Abortion Medication Product Portfolio
  36. 7.6.5 Shanghai Xinhualian Pharmaceutical Co., Ltd Recent Developments
  37. 7.7 Sun Pharma
  38. 7.7.1 Sun Pharma Company Information
  39. 7.7.2 Sun Pharma Business Overview
  40. 7.7.3 Sun Pharma Abortion Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sun Pharma Abortion Medication Product Portfolio
  42. 7.7.5 Sun Pharma Recent Developments
8 North America
  1. 8.1 North America Abortion Medication Market Size by Type
  2. 8.1.1 North America Abortion Medication Revenue by Type (2021-2032)
  3. 8.1.2 North America Abortion Medication Sales by Type (2021-2032)
  4. 8.1.3 North America Abortion Medication Price by Type (2021-2032)
  5. 8.2 North America Abortion Medication Market Size by Application
  6. 8.2.1 North America Abortion Medication Revenue by Application (2021-2032)
  7. 8.2.2 North America Abortion Medication Sales by Application (2021-2032)
  8. 8.2.3 North America Abortion Medication Price by Application (2021-2032)
  9. 8.3 North America Abortion Medication Market Size by Country
  10. 8.3.1 North America Abortion Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Abortion Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Abortion Medication Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Abortion Medication Market Size by Type
  2. 9.1.1 Europe Abortion Medication Revenue by Type (2021-2032)
  3. 9.1.2 Europe Abortion Medication Sales by Type (2021-2032)
  4. 9.1.3 Europe Abortion Medication Price by Type (2021-2032)
  5. 9.2 Europe Abortion Medication Market Size by Application
  6. 9.2.1 Europe Abortion Medication Revenue by Application (2021-2032)
  7. 9.2.2 Europe Abortion Medication Sales by Application (2021-2032)
  8. 9.2.3 Europe Abortion Medication Price by Application (2021-2032)
  9. 9.3 Europe Abortion Medication Market Size by Country
  10. 9.3.1 Europe Abortion Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Abortion Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Abortion Medication Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Abortion Medication Market Size by Type
  2. 10.1.1 China Abortion Medication Revenue by Type (2021-2032)
  3. 10.1.2 China Abortion Medication Sales by Type (2021-2032)
  4. 10.1.3 China Abortion Medication Price by Type (2021-2032)
  5. 10.2 China Abortion Medication Market Size by Application
  6. 10.2.1 China Abortion Medication Revenue by Application (2021-2032)
  7. 10.2.2 China Abortion Medication Sales by Application (2021-2032)
  8. 10.2.3 China Abortion Medication Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Abortion Medication Market Size by Type
  2. 11.1.1 Asia Abortion Medication Revenue by Type (2021-2032)
  3. 11.1.2 Asia Abortion Medication Sales by Type (2021-2032)
  4. 11.1.3 Asia Abortion Medication Price by Type (2021-2032)
  5. 11.2 Asia Abortion Medication Market Size by Application
  6. 11.2.1 Asia Abortion Medication Revenue by Application (2021-2032)
  7. 11.2.2 Asia Abortion Medication Sales by Application (2021-2032)
  8. 11.2.3 Asia Abortion Medication Price by Application (2021-2032)
  9. 11.3 Asia Abortion Medication Market Size by Country
  10. 11.3.1 Asia Abortion Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Abortion Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Abortion Medication Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Abortion Medication Market Size by Type
  2. 12.1.1 SAMEA Abortion Medication Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Abortion Medication Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Abortion Medication Price by Type (2021-2032)
  5. 12.2 SAMEA Abortion Medication Market Size by Application
  6. 12.2.1 SAMEA Abortion Medication Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Abortion Medication Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Abortion Medication Price by Application (2021-2032)
  9. 12.3 SAMEA Abortion Medication Market Size by Country
  10. 12.3.1 SAMEA Abortion Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Abortion Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Abortion Medication Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Abortion Medication Value Chain Analysis
  2. 13.1.1 Abortion Medication Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Abortion Medication Production Mode & Process
  6. 13.2 Abortion Medication Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Abortion Medication Distributors
  9. 13.2.3 Abortion Medication Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst